Operator Ladies and gentlemen, thank you for standing by, and welcome to the Fourth Quarter and Full Year 2020 Coherus BioSciences Conference Call. [Operator Instructions] I would now like to turn the conference over to your host today, Mr. McDavid Stilwell. Sir, please go ahead. McDavid Stilwell -- Executive Vice President, Corporate Development, Investor Relations, and Financial Strategy Thank you. Good afternoon, everyone, and thank you for joining us. We issued a press release earlier announcing our 2020 fiscal year and fourth quarter results and the release can be found on the Coherus BioSciences website. Today's call includes forward-looking statements regarding Coherus' current expectations. These statements include, but are not limited to, our ability to advance our biosimilar and immuno-oncology product candidates through development and registration.